Monterey Bio Acquisition
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Monterey Bio Acquisition generated cash of -$1,004,040, which is less than the previous year. Cash used in financing activities reached the amount of -$95,364,717 last year. Net change in cash is therefore -$365,002.
Cash Flow
| 2020 | 0 | 0 | 60 |
|---|---|---|---|
| 2021 | -939.68K | -116.15M | 117.57M |
| 2022 | -1.00M | 96.00M | -95.36M |
MTRY Cash Flow Statement (2020 – 2022)
| 2022 | 2021 | 2020 | |
|---|---|---|---|
Cash at beginning of period | 510.81K | 25K | 0 |
Operating activities | |||
Net income | -1.27M | -583.22K | -2 |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 |
Cash generated by operating activities | -1.00M | -939.68K | 0 |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | 96.00M | -116.15M | 0 |
Financing activities | |||
Common Stock Issued | 0 | 112.7M | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | -96.05M | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 |
Cash used in financing activities | -95.36M | 117.57M | 60 |
Net Change In Cash | -365.00K | 485.81K | 60 |
Cash at end of period | 145.81K | 510.81K | 60 |
| Data source | Data source |